234 related articles for article (PubMed ID: 29485235)
1. Extension of peripheral nonperfusion in eyes with retinal vein occlusion during intravitreal dexamethasone treatment.
Rezar-Dreindl S; Eibenberger K; Buehl W; Weigert G; Georgopoulos M; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2018 Jun; 96(4):e455-e459. PubMed ID: 29485235
[TBL] [Abstract][Full Text] [Related]
2. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
[TBL] [Abstract][Full Text] [Related]
4. Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion:
Pielen A; Feltgen N; Hattenbach LO; Hoerauf H; Bertelmann T; Quiering C; Vögeler J; Priglinger S; Lang GE; Schmitz-Valckenberg S; Wolf A; Rehak M
Curr Eye Res; 2020 May; 45(5):604-614. PubMed ID: 31665935
[No Abstract] [Full Text] [Related]
5. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
Gu X; Yu X; Song S; Dai H
Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema.
Choi EY; Kang HG; Lee SC; Kim M
BMC Ophthalmol; 2019 Apr; 19(1):92. PubMed ID: 30999889
[TBL] [Abstract][Full Text] [Related]
8. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
10. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
11. SAFETY AND FEASIBILITY OF A NOVEL 25-GAUGE BIODEGRADABLE IMPLANT OF DEXAMETHASONE FOR TREATMENT OF MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION: A PHASE I CLINICAL TRIAL.
Cunha RB; Siqueira RC; Messias A; Scott IU; Fialho SL; Cunha-Junior ADS; Jorge R
Retin Cases Brief Rep; 2018 Winter; 12(1):50-58. PubMed ID: 27632583
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
Simsek M; Citirik M; Ozates S; Ozkoyuncu D
Indian J Ophthalmol; 2018 Jun; 66(6):831-836. PubMed ID: 29785994
[TBL] [Abstract][Full Text] [Related]
13. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
14. Changes in macular function after ozurdex for retinal vein occlusion.
Querques G; Cascavilla ML; Cavallero E; Triolo G; Querques L; Lattanzio R; Cicinelli MV; Preziosa C; Borrelli E; Bandello F
Optom Vis Sci; 2014 Jul; 91(7):760-8. PubMed ID: 24927143
[TBL] [Abstract][Full Text] [Related]
15. Changes in choroidal thickness after intravitreal dexamethasone implant injection in retinal vein occlusion.
Lee EK; Han JM; Hyon JY; Yu HG
Br J Ophthalmol; 2015 Nov; 99(11):1543-9. PubMed ID: 25883084
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment.
Altunel O; Duru N; Goktas A; Ozkose A; Goktas E; Atas M
Int Ophthalmol; 2017 Apr; 37(2):333-339. PubMed ID: 27221365
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
[TBL] [Abstract][Full Text] [Related]
18. Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
Querques L; Querques G; Lattanzio R; Gigante SR; Del Turco C; Corradetti G; Cascavilla ML; Bandello F
Ophthalmologica; 2013; 229(1):21-5. PubMed ID: 23006995
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography angiography in retinal vein occlusion treated with dexamethasone implant: a new test for follow-up evaluation.
Glacet-Bernard A; Sellam A; Coscas F; Coscas G; Souied EH
Eur J Ophthalmol; 2016 Aug; 26(5):460-8. PubMed ID: 27405288
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
